Nomura Holdings
PBE icon

Nomura Holdings’s Invesco Biotechnology & Genome ETF PBE Stock Holding History

Nomura Holdings’s Portfolio PBE Stock Details PBE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-684
Closed -$24K – 2218
2013
Q3 		$24K Buy
+684
New +$22.7K ﹤0.01% 2164

Other funds holding PBE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TAM
Trillium Asset Management Boston, Massachusetts $3.01B AUM 19.96% 1-Year Est. Return
NCM
Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
SAM
SignalPoint Asset Management Springfield, Missouri $411M AUM 23.81% 1-Year Est. Return
WB
Webster Bank Waterbury, Connecticut $1.06B AUM 19.66% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Nomura Holdings's PBE Position: Q4 2013 in Review

Nomura Holdings sold out of Invesco Biotechnology & Genome ETF (PBE) in Q4 2013, closing a stake of 684 shares — an estimated $24K sold.

Nomura Holdings first reported a position in PBE in Q3 2013 and held it in 1 quarter. The position peaked at $24K in Q3 2013. 60 funds tracked by Wall St. Rank hold PBE as of Q4 2013.

  • Nomura Holdings reported no remaining Invesco Biotechnology & Genome ETF position as of Q4 2013 after selling out during the quarter.
  • Nomura Holdings sold 684 Invesco Biotechnology & Genome ETF shares in Q4 2013, an estimated $24K.
  • Nomura Holdings first reported a position in Invesco Biotechnology & Genome ETF in Q3 2013 and held it in 1 quarter.
  • Nomura Holdings's Invesco Biotechnology & Genome ETF position peaked at $24K in Q3 2013.
  • 60 funds tracked by Wall St. Rank held Invesco Biotechnology & Genome ETF as of Q4 2013.

Based on Nomura Holdings's 13F filing for Q4 2013, filed 14 Feb 2014.